Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil in advanced congestive heart failure
NCT00309816Phase 3Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Dec 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of sildenafil in heart failure (HF), sponsored by Massachusetts General Hospital. Primary endpoint: Exercise capacity measured by exercise stress test. Started Dec 2001; status: completed.
02
Drugs
sildenafil
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00309816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00309816.